Cargando…
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
Background: Glioblastoma (GBM) is the most common type of brain cancer with poor survival outcomes and unsatisfactory response to current therapeutic strategies. Recent studies have demonstrated that ferroptosis-related genes (FRGs) are linked with the occurrence and development of GBM and may becom...
Autores principales: | Zhu, Xiaopeng, Zhou, Yuxiang, Ou, Yangqian, Cheng, Zebo, Han, Deqing, Chu, Zhou, Pan, Sian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312442/ https://www.ncbi.nlm.nih.gov/pubmed/34244461 http://dx.doi.org/10.18632/aging.203257 |
Ejemplares similares
-
Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021) -
Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
por: Zhu, Xiaopeng, et al.
Publicado: (2021) -
A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer
por: Liu, Shi-jin, et al.
Publicado: (2021) -
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022) -
Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)